Rosenblat, Joshua D
$1,000,000.00 CAD
- Department
- Canadian Institutes of Health Research
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- March 1, 2023 – February 28, 2025
- Reference
- cihr-irsc:236-2022-2023-Q4-00513
Published purpose
The specific objectives of this funding opportunity are to: • Generate new data and evidence relating to the therapeutic efficacy and safety of psilocybin-assisted psychotherapy for substance use and mental health disorders; • Facilitate consideration and application of new evidence to inform ongoing and future development of policies, practices and programs related to psilocybin-assisted psychotherapy; • Strengthen research excellence and ensure maximum research impact through consideration of diverse biological and/or socio-cultural identity factors in research design, and diverse research methods such as those based in Indigenous ways of knowing.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.